Breaking News, Promotions & Moves

CiVi Biopharma Appoints New CEO

Mr. Jacobovitz comes with decades of experience

CiVi Biopharma has appointed Shalom “Shal” Jacobovitz as chief executive officer and a director on their Board of Directors effective February 2, 2018.     Mr. Jacobovitz most recently served as chief executive officer of the American College of Cardiology, and before that, as president of Actelion Pharmaceuticals.   “We are extremely pleased to welcome Shal to CiVi Biopharma,” said Aaron Davis, chief executive officer of Boxer Capital, and executive chairman of CiVi Biopharma.  ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters